Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Curculigoside
Cat. No.:
0225LY-0973
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Curculigoside is a potent antioxidant that protects endothelial cells from oxidative damage and regulates bone metabolism by promoting osteogenesis while inhibiting osteoclastogenesis.
Synonym:
Curculigoside A; 85643-19-2; [5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl 2,6-dimethoxybenzoate; beta-D-Glucopyranoside, 2-(((2,6-dimethoxybenzoyl)oxy)methyl)-4-hydroxyphenyl; beta-D-Glucopyranoside, 2-[[(2,6-dimethoxybenzoyl)oxy]methyl]-4-hydroxyphenyl; Curculigoside,(S); MFCD00800689
CAS No.:
85643-19-2
Compound CID:
158845
Formula:
C22H26O11
Formula Weight:
466.44
Specification
Relative Density:
1.45 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Curculigoside can be used in bone research to study its protective effects against oxidative stress-induced bone loss.
Library Information
Target:
JAK; NF-κB; STAT
Receptor:
JAK; NF-κB; STAT
Pathways:
NF-κB; Stem cell regulation; Oxidation-reduction; JAK/STAT signaling; Tyrosine kinase/adaptors
Plate Number:
AOCL-13
Plate Location:
e4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
84 mg/mL; 180.09 mM
Ethanol Max Solubility:
84 mg/mL; 180.09 mM
Solubility:
Soluble in pyridine, methanol, etc.
